Zolpidem tartrate 5 MG Oral Tablet — RxCUI 854876
RxNorm drug concept · Semantic clinical drug
RxCUI 854876
Semantic clinical drug · SCD
● Current RxNorm concept 66 FDA products
222 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI854876
Official nameZolpidem tartrate 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped66
Package NDCs mapped222
Reported Medicaid activity (SDUD)1,315,231 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Zolpidem: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Zolpidem is a prescription sleep medicine for insomnia. Depending on which form your doctor prescribed, it can help you fall asleep faster at bedtime, sleep through the night witho...
- What exactly is zolpidem supposed to do for me?
- This is one of the most important things to know: zolpidem can impair your driving and mental sharpness the next morning, even if you feel wide awake and fine. The risk goes up if...
- Is it safe to drive to work the morning after taking zolpidem?
🕸️ Concept Web — How Zolpidem tartrate 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Zolpidem tartrate 5 MG Oral Tablet
RxCUI 854876 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Zolpidem
39993IN -
Zolpidem tartrate
221183PIN
-
Zolpidem
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ambien
131725BN
-
Ambien
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Zolpidem Oral Tablet
374364SCDF -
Zolpidem tartrate Oral Tablet
2648191SCDFP -
Zolpidem Oral Product
1156259SCDG -
Zolpidem Pill
1156260SCDG -
Zolpidem tartrate Oral Product
2660744SCDGP -
Zolpidem tartrate Pill
2661550SCDGP -
Zolpidem Oral Tablet [Ambien]
367881SBDF -
Zolpidem tartrate Oral Tablet [Ambien]
2657285SBDFP - +5 more in this family
-
Zolpidem Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Zolpidem tartrate 5 MG
836646SCDC -
Zolpidem tartrate 5 MG Oral Tablet [Ambien]
854878SBD -
Zolpidem tartrate 5 MG [Ambien]
854877SBDC
-
Zolpidem tartrate 5 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Zolpidem tartrate 5 MG
SCDC · 836646 -
Zolpidem Oral Tablet
SCDF · 374364 -
Zolpidem tartrate Oral Tablet
SCDFP · 2648191 -
Zolpidem Oral Product
SCDG · 1156259 -
Zolpidem Pill
SCDG · 1156260 -
Zolpidem tartrate Oral Product
SCDGP · 2660744 -
Zolpidem tartrate Pill
SCDGP · 2661550
Brand-Name Concepts
-
Zolpidem tartrate 5 MG Oral Tablet [Ambien]
SBD · 854878 -
Zolpidem tartrate 5 MG [Ambien]
SBDC · 854877 -
Zolpidem Oral Tablet [Ambien]
SBDF · 367881 -
Zolpidem tartrate Oral Tablet [Ambien]
SBDFP · 2657285 -
Ambien Oral Product
SBDG · 1170672 -
Ambien Pill
SBDG · 1170673 -
Ambien
BN · 131725
📦 FDA Products & Package NDCs
66 products · 222 package NDCs
222 package NDCs map to RxCUI 854876 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 76420-0416-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-416-30) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 76420-0416-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-416-60) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 76420-0416-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-416-90) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 76420-0417-00 | 1000 TABLET, FILM COATED in 1 BOTTLE (76420-417-00) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 76420-0417-01 | 100 TABLET, FILM COATED in 1 BOTTLE (76420-417-01) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 76420-0417-05 | 500 TABLET, FILM COATED in 1 BOTTLE (76420-417-05) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 76420-0417-30 | 30 TABLET, FILM COATED in 1 BOTTLE (76420-417-30) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 76420-0417-60 | 60 TABLET, FILM COATED in 1 BOTTLE (76420-417-60) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 76420-0417-90 | 90 TABLET, FILM COATED in 1 BOTTLE (76420-417-90) | Zolpidem Tartrate | Asclemed USA, Inc. | 2025-07-24 |
| 80425-0087-01 | 30 TABLET, FILM COATED in 1 BOTTLE (80425-0087-1) | Zolpidem Tartrate | Advanced Rx of Tennessee, LLC | 2007-05-04 |
| 80425-0087-02 | 60 TABLET, FILM COATED in 1 BOTTLE (80425-0087-2) | Zolpidem Tartrate | Advanced Rx of Tennessee, LLC | 2007-05-04 |
| 80425-0165-01 | 30 TABLET in 1 BOTTLE (80425-0165-1) | Zolpidem Tartrate | Advanced Rx Pharmacy of Tennessee, LLC | 2007-09-05 |
| 80425-0165-02 | 60 TABLET in 1 BOTTLE (80425-0165-2) | Zolpidem Tartrate | Advanced Rx Pharmacy of Tennessee, LLC | 2007-09-05 |
| 80425-0322-01 | 30 TABLET in 1 BOTTLE (80425-0322-1) | Zolpidem Tartrate | Advanced Rx Pharmacy of Tennessee, LLC | 2023-04-13 |
| 80425-0322-02 | 60 TABLET in 1 BOTTLE (80425-0322-2) | Zolpidem Tartrate | Advanced Rx Pharmacy of Tennessee, LLC | 2023-04-13 |
| 80425-0322-03 | 90 TABLET in 1 BOTTLE (80425-0322-3) | Zolpidem Tartrate | Advanced Rx Pharmacy of Tennessee, LLC | 2023-04-13 |
| 80425-0430-01 | 30 TABLET in 1 BOTTLE (80425-0430-1) | Zolpidem | Advanced Rx of Tennessee, LLC | 2024-08-13 |
| 80425-0430-02 | 60 TABLET in 1 BOTTLE (80425-0430-2) | Zolpidem | Advanced Rx of Tennessee, LLC | 2024-08-13 |
| 80425-0430-03 | 90 TABLET in 1 BOTTLE (80425-0430-3) | Zolpidem | Advanced Rx of Tennessee, LLC | 2024-08-13 |
| 80425-0513-01 | 30 TABLET, COATED in 1 BOTTLE (80425-0513-1) | Zolpidem Tartrate | Advanced Rx of Tennessee, LLC | 2025-04-15 |
| 80425-0513-02 | 60 TABLET, COATED in 1 BOTTLE (80425-0513-2) | Zolpidem Tartrate | Advanced Rx of Tennessee, LLC | 2025-04-15 |
| 80425-0513-03 | 90 TABLET, COATED in 1 BOTTLE (80425-0513-3) | Zolpidem Tartrate | Advanced Rx of Tennessee, LLC | 2025-04-15 |
Observed labelers:
Aphena Pharma Solutions - Tennessee, LLC (37) ·
Asclemed USA, Inc. (26) ·
Bryant Ranch Prepack (26) ·
Proficient Rx LP (17) ·
A-S Medication Solutions (13) ·
Golden State Medical Supply, Inc. (12)
· +22 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.